🔬

Cas13 gRNA Design for Silencing MAPT (Tau) Transcripts in Alzheimer's Disease — Analysis

active
analysis Created: 2026-04-21T01:27:50 By: orchestra-ci Quality: 40% ✓ SciDEX ID: analysis-SDA-BIOMNI-CAS13_PR-d6f415f0
🔬 Analysis Details
Cas13 gRNA Design for Silencing MAPT (Tau) Transcripts in Alzheimer's Disease
completed neurodegeneration / biomni_parity 🧪 0 hypotheses 📓 0 notebooks $0.02 by a4c450f7-df61-405c-9e95-16d08119c5be
Can optimized Cas13 guide RNAs selectively silence pathogenic MAPT splice variants (4R-tau) while preserving normal 3R-tau expression in neurons?
Gap: h-var-95b0f9a6bc
🔬 View Full Analysis →📊 Report ↗
Parent Context
🔬
Parent Analysis
Cas13 gRNA Design for Silencing MAPT (Tau) Transcripts in Alzheimer's Disease
Metadatasource: ci_notebook_coverage
stubTrue
sourceci_notebook_coverage
file_sha25690021f23a11a8ff1931aa34bac69e158d9ac4b3455486642d9b0207110a283da
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
15%
Debates
0
Incoming
3
Outgoing
1
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.